oseltamivir has been researched along with Pneumonia in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (21.43) | 29.6817 |
2010's | 19 (45.24) | 24.3611 |
2020's | 14 (33.33) | 2.80 |
Authors | Studies |
---|---|
Aldhahri, FA; Alghanem, AF; Althemery, AU | 1 |
Ando, Y; Kawai, M; Kida, H; Kobayashi, M; Matsuno, K; Naito, A; Nobori, H; Noshi, T; Okamatsu, M; Sakoda, Y; Sanaki, T; Sato, A; Shishido, T; Taniguchi, K; Toba, S; Yoshida, R | 1 |
Bohn, J; Carruth, A; Cocoros, NM; Cosgrove, A; Dutcher, SK; Francis, H; Htoo, PT; Measer, G; Orr, R; Sorbello, A; Toh, S | 1 |
Deshpande, A; Haessler, S; Higgins, T; Imrey, PB; Klompas, M; Lindenauer, PK; Pallotta, AM; Rothberg, MB; Yu, PC; Zilberberg, MD | 1 |
Graham, H; Gwee, A; Hume-Nixon, M; Mulholland, K; Russell, F | 1 |
Bai, H; Chen, R; Cui, X; Hong, J; Liu, Q; Liu, X; Lou, K; Wang, F; Yang, Y | 1 |
Al Rumaih, Z; Chaudhri, G; Karupiah, G; Kc, R; Kels, MJT; Malley, R; Ng, E; Pandey, P | 1 |
Desvergez, A; Gazaille, V; Lilienthal, F; Paganin, F; Verdier, V; Winer, A | 1 |
Monto, AS; Whitley, RJ | 1 |
Behillil, S; Chicheportiche, T; de Prost, N; Dessap, AM; Enouf, V; Ferré, A; Fourati, S; Georger, JF; Guérin, L; Luyt, CE; Maury, E; May, F; Mayaux, J; Roux, D; Sonneville, R; Tandjaoui-Lambiotte, Y; van der Werf, S; Voiriot, G | 1 |
Arabi, YM; Fowler, R; Hayden, FG | 1 |
Amaro, R; Bassetti, M; Cilloniz, C; Giacobbe, DR; Graziano, E; Russo, A; Soriano, A; Torres, A; Vena, A | 1 |
Bekci, T | 1 |
Chou, SC; Fang, YH; Hsu, TH; Lin, TY; Liu, CH; Perng, PC; Wu, JY | 1 |
Boikos, C; Doll, MK; Gore, G; Kraicer-Melamed, H; Quach, C; Winters, N | 1 |
Dickey, BF; Evans, SE; Gilbert, BE; Kirkpatrick, CT; Leiva-Juarez, MM; Markesich, D; Scott, B; Tuvim, MJ | 1 |
Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K | 1 |
Beutels, P; Bongard, E; Brugman, C; Butler, CC; Chlabicz, S; Coenen, S; Colliers, A; Cook, J; Davies, M; de Jong, M; De Paor, M; De Sutter, A; Francis, NA; Glinz, D; Godycki-Ćwirko, M; Goossens, H; Holmes, J; Ieven, M; Lindbaek, M; Little, P; Martinón-Torres, F; Moragas, A; Munck Aabenhus, R; Pauer, J; Pfeiferová, M; Radzeviciene-Jurgute, R; Saville, B; Sundvall, PD; Torres, A; Touboul, P; van der Velden, AW; Varthalis, D; Verheij, T | 1 |
Cabral, E; Carratalá, J; Cordero, E; Cruzado, JM; Delgado, JF; Gavaldá, J; Gómez-Bravo, MÁ; López-Medrano, F; Marcos, MÁ; Pérez-Romero, P; Sabé, N | 1 |
Jurek, T; Kuchar, E; Rorat, M; Szenborn, L | 1 |
Del Mar, CB; Doshi, P; Hama, R; Heneghan, CJ; Howick, J; Jefferson, T; Jones, MA; Mahtani, KR; Nunan, D; Onakpoya, I; Spencer, EA; Thompson, MJ | 1 |
Chen, J; Hu, J; King, CC; Mao, S; Pan, H; Pan, Q; Teng, Z; Wu, F; Zhang, H; Zhang, X; Zheng, Y | 1 |
Chang, CC; Chen, PH; Shih, YL | 1 |
Bello, S; de Pablo, F; Fandos, S; Figueredo, AL; Minchole, E; Omeñaca, M; Panadero, C; Royo, L; Vengoechea, JJ | 1 |
Boikos, C; Caya, C; Delisle, G; Doll, MK; Dolph, M; Gore, G; Kraicer-Melamed, H; Quach, C; Winters, N | 1 |
Barr, CE; Moscona, A; Peters, PH; Schulman, KL | 1 |
Burgaleta, C; Callejas, M; Galán, JC; García-Suárez, J; Martín, Y; Rodriguez-Dominguez, M | 1 |
Aardema, H; Boucher, CA; de Jager, CM; Riezebos-Brilman, A; Tulleken, JE; van den Biggelaar, RJ; Wolters, BA | 1 |
Campins, A; Carratalà, J; Fariñas, MC; Gudiol, F; López-Medrano, F; Martínez-Montauti, J; Moreno, A; Oteo, JA; Pachón, J; Paño-Pardo, JR; Rodríguez-Baño, J; Segura, F; Torre-Cisneros, J; Viasus, D; Villoslada, A | 1 |
Dembiński, Ł; Jackowska, T; Marczyńska, M; Radzikowski, A; Smalisz-Skrzypczyk, K; Talarek, E | 1 |
Abecasis, M; Cannata-Ortiz, MJ; Cordonnier, C; de la Camara, R; Einsele, H; Engelhard, D; Espigado, I; Gonzalez-Vicent, M; Halter, J; Ljungman, P; Martino, R; Mohty, B; Nieto Campuzano, JB; Perez-Bercoff, L; Sucak, G; Ullmann, AJ; Vázquez, L; Ward, KN | 1 |
Cao, B; Cao, ZX; Chen, W; Chen, Y; Deng, GM; Du, WB; Gu, L; Guo, CP; Hu, K; Jia, HY; Jiang, XL; Li, LJ; Li, XL; Liang, LR; Liang, ZA; Wang, C; Xiao, YH; Xu, Z; Yan, XX; Yang, M; Yang, SG; Yang, YD; Yu, HJ; Yu, KJ; Zhang, CL; Zhang, W; Zou, Q | 1 |
Hak, E; Koopmans, M; Niesters, HG; Rahamat-Langendoen, JC; Riezebos-Brilman, A; Schölvinck, EH; Tutuhatunewa, ED | 1 |
Ersbøll, AS; Hedegaard, M; Hesselvig, AB; Krebs, L | 1 |
Nordstrom, BL; Sung, I; Suter, P; Szneke, P | 1 |
Hiraga, T; Ito, M; Iwasaki, T; Kitada, S; Maekura, R; Miki, K; Miki, M; Mori, M; Motone, M; Naka, N; Namba, Y; Niinaka, M; Yoshimura, K | 1 |
Leach, L; Raymond, LW | 1 |
Blumentals, WA; Gums, JG; Pelletier, EM | 1 |
Ginns, LC; Ison, MG; Sharma, A; Shepard, JA; Wain, JC | 1 |
Rosen, DS | 1 |
Gross, PA | 1 |
Vogel, GE | 1 |
8 review(s) available for oseltamivir and Pneumonia
Article | Year |
---|---|
Review of the role of additional treatments including oseltamivir, oral steroids, macrolides, and vitamin supplementation for children with severe pneumonia in low- and middle-income countries.
Topics: Anti-Bacterial Agents; Ascorbic Acid; Child; Developing Countries; Dietary Supplements; Humans; Infant; Macrolides; Micronutrients; Oseltamivir; Pneumonia; Vitamin A; Vitamin D; Vitamin D Deficiency; Vitamins; Zinc | 2022 |
Critical care management of adults with community-acquired severe respiratory viral infection.
Topics: Adult; Antiviral Agents; Community-Acquired Infections; Coronavirus Infections; COVID-19; Critical Care; Critical Illness; Evidence-Based Medicine; Humans; Influenza, Human; Intensive Care Units; Macrolides; Noninvasive Ventilation; Oseltamivir; Pneumonia; Pneumonia, Viral; Respiration, Artificial; Severe Acute Respiratory Syndrome; Severity of Illness Index | 2020 |
Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials.
Topics: Acids, Carbocyclic; Administration, Intravenous; Administration, Oral; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Randomized Controlled Trials as Topic | 2021 |
Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses.
Topics: Antiviral Agents; Disease Outbreaks; Enzyme Inhibitors; Hospitalization; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pneumonia; Zanamivir | 2017 |
Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Cross Infection; Diagnosis, Differential; Disease Management; Drug Resistance, Viral; HN Protein; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Inpatients; Kidney Diseases; Organ Transplantation; Oseltamivir; Outpatients; Pneumonia; Postoperative Complications; Superinfection; Zanamivir | 2013 |
Neuraminidase inhibitors for preventing and treating influenza in adults and children.
Topics: Adult; Antiviral Agents; Child; Drug Evaluation; Enzyme Inhibitors; Europe; Health Status; Humans; Influenza, Human; Japan; Legislation, Drug; Neuraminidase; Oseltamivir; Pneumonia; Publication Bias; Randomized Controlled Trials as Topic; United Kingdom; United States; Zanamivir | 2014 |
Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Disease Outbreaks; Enzyme Inhibitors; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Middle Aged; Neuraminidase; Observational Studies as Topic; Oseltamivir; Pandemics; Pneumonia; Young Adult; Zanamivir | 2017 |
Vaccines for pneumonia and new antiviral therapies.
Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir | 2001 |
1 trial(s) available for oseltamivir and Pneumonia
Article | Year |
---|---|
Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC
Topics: Activities of Daily Living; Antiviral Agents; Cost-Benefit Analysis; Female; Fever; Headache; Hospitalization; Humans; Influenza, Human; Male; Multicenter Studies as Topic; Myalgia; Nonprescription Drugs; Oseltamivir; Pneumonia; Pragmatic Clinical Trials as Topic; Prescription Drugs; Self Care; Symptom Assessment; Time Factors | 2018 |
33 other study(ies) available for oseltamivir and Pneumonia
Article | Year |
---|---|
Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.
Topics: Community-Acquired Infections; Humans; Influenza, Human; Oseltamivir; Pneumonia; Retrospective Studies | 2021 |
Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.
Topics: A549 Cells; Animals; Antiviral Agents; Chemokines; Cytokines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Lung; Mice; Mice, Inbred BALB C; Morpholines; Orthomyxoviridae Infections; Oseltamivir; Pneumonia; Pyridones; Sequence Analysis; Triazines; Virus Replication | 2022 |
Evaluating Confounding Control in Estimations of Influenza Antiviral Effectiveness in Electronic Health Plan Data.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antiviral Agents; Electronics; Hospitalization; Humans; Influenza, Human; Oseltamivir; Pneumonia; Retrospective Studies | 2022 |
Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Community-Acquired Infections; Hospitalization; Humans; Influenza, Human; Oseltamivir; Pneumonia; Retrospective Studies | 2022 |
Determination of the synergistic anti-influenza effect of Huangqin Su tablet and Oseltamivir and investigation of mechanism of the tablet based on gut microbiota and network pharmacology.
Topics: Animals; DNA, Ribosomal; Female; Gastrointestinal Microbiome; Influenza, Human; Male; Mice; Mice, Inbred ICR; Network Pharmacology; Oseltamivir; Pneumonia; Scutellaria baicalensis | 2023 |
Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.
Topics: Animals; Antiviral Agents; COVID-19; Cytokines; Etanercept; Humans; Inflammation; Influenza A virus; Influenza, Human; Mice; Morbidity; Oseltamivir; Pneumonia; SARS-CoV-2 | 2023 |
Severe forms of influenza infections admitted in intensive care units: Analysis of mortality factors.
Topics: Adult; Coinfection; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Oseltamivir; Pneumonia; Respiratory Distress Syndrome; Retrospective Studies | 2023 |
Resistance of Influenza Virus to Antiviral Medications.
Topics: Antiviral Agents; Cohort Studies; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Pneumonia; Respiratory Distress Syndrome | 2020 |
Oseltamivir Resistance in Severe Influenza A(H1N1)pdm09 Pneumonia and Acute Respiratory Distress Syndrome: A French Multicenter Observational Cohort Study.
Topics: Antiviral Agents; Cohort Studies; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Neuraminidase; Oseltamivir; Pneumonia; Respiratory Distress Syndrome | 2020 |
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain.
Topics: Aged; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Community-Acquired Infections; Female; Humans; Italy; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Oseltamivir; Pneumococcal Infections; Pneumonia; Retrospective Studies; Spain; Staphylococcal Infections; Streptococcus pneumoniae | 2020 |
"Reversed halo sign" on 3D CT in COVID-19.
Topics: Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Body Fluids; Coronavirus Infections; COVID-19; Drug Therapy, Combination; Humans; Hydroxychloroquine; Imaging, Three-Dimensional; Male; Nasopharynx; Oseltamivir; Pandemics; Pneumonia; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Combined aerosolized Toll-like receptor ligands are an effective therapeutic agent against influenza pneumonia when co-administered with oseltamivir.
Topics: Administration, Oral; Aerosols; Animals; Drug Interactions; Humans; Influenza A Virus, H3N2 Subtype; Ligands; Lipopeptides; Male; Mice; Oligodeoxyribonucleotides; Oseltamivir; Pneumonia; Toll-Like Receptor 2; Toll-Like Receptor 6; Toll-Like Receptor 9; Toll-Like Receptors | 2018 |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir | 2017 |
The clinical course of late diagnosed fatal cases of A (H1N1) influenza in Poland.
Topics: Adult; Age of Onset; Aged; Antiviral Agents; Arthritis; Cause of Death; Coinfection; Comorbidity; Cross Infection; Delayed Diagnosis; Disease Progression; Fatty Liver; Female; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia; Poland; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Survival Rate; Young Adult | 2013 |
A case report of avian influenza H7N9 killing a young doctor in Shanghai, China.
Topics: Adult; Anti-Bacterial Agents; China; Glucocorticoids; Humans; Immunoglobulins; Influenza A Virus, H7N9 Subtype; Influenza, Human; Lung; Male; Oseltamivir; Phylogeny; Physicians; Pneumonia; Radiography; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral | 2015 |
Successful management of atypical pneumonia in acute respiratory distress syndrome patient during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Ceftriaxone; Cesarean Section; Female; Fetal Monitoring; Humans; Lung; Oseltamivir; Oxygen Inhalation Therapy; Pneumonia; Pregnancy; Pregnancy Complications; Radiography; Respiratory Distress Syndrome | 2015 |
Seasonal Influenza A H1N1pdm09 Virus and Severe Outcomes: A Reason for Broader Vaccination in Non-Elderly, At-Risk People.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pneumonia; Respiratory Distress Syndrome; Retrospective Studies; Risk Factors; Seasons; Shock, Septic; Treatment Outcome; Young Adult | 2016 |
Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Influenza, Human; Male; Middle Aged; Oseltamivir; Pneumonia; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2008 |
Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non-Hodgkin lymphoma.
Topics: Adult; Anemia, Hemolytic; Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Oseltamivir; Pneumonia; Reverse Transcriptase Polymerase Chain Reaction; Splenectomy | 2010 |
[Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
Topics: Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pneumonia; Zanamivir | 2010 |
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bacterial Infections; Disease Outbreaks; Female; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Male; Middle Aged; Obesity; Oseltamivir; Pandemics; Pneumonia; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Treatment Outcome | 2011 |
[Clinical course of influenza A(H1N1)v in children treated in Warsaw in season 2009/2010].
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Communicable Diseases, Emerging; Comorbidity; Cough; Female; Fever; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Poland; Retrospective Studies; Seasons; Treatment Outcome; Urban Population | 2010 |
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Hematopoietic Stem Cell Transplantation; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lymphopenia; Middle Aged; Oseltamivir; Pandemics; Pneumonia; Risk Factors; Treatment Outcome; Vaccination; Young Adult | 2011 |
Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus.
Topics: Antiviral Agents; Humans; Influenza A Virus, H1N1 Subtype; Oseltamivir; Pneumonia | 2012 |
Influenza in the immediate post-pandemic era: a comparison with seasonal and pandemic influenza in hospitalized patients.
Topics: Adolescent; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Influenza, Human; Inpatients; Male; Middle Aged; Orthomyxoviridae; Oseltamivir; Pneumonia; Retrospective Studies; Severity of Illness Index; Young Adult | 2012 |
[Report: complicated influenza A(H1N1) in a second-trimester pregnancy].
Topics: Adult; Antibiotic Prophylaxis; Antiviral Agents; Cesarean Section; Female; Humans; Infant, Extremely Premature; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Oseltamivir; Pneumonia; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Second; Radiography; Risk Factors | 2012 |
Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir.
Topics: Acetamides; Adult; Anti-Bacterial Agents; Antiviral Agents; Female; Hospitalization; Humans; Influenza, Human; Insurance Claim Review; Male; Middle Aged; Oseltamivir; Pneumonia; Proportional Hazards Models; Retrospective Studies; Risk Factors | 2005 |
[A case of pneumonitis suspected to be induced by Oseltamivir].
Topics: Acetamides; Adult; Antiviral Agents; Diagnosis, Differential; Humans; Male; Oseltamivir; Pneumonia; Radiography; Severe Acute Respiratory Syndrome | 2006 |
Treatment of post-influenza pneumonia in health care workers.
Topics: Anti-Infective Agents; Antiviral Agents; Health Personnel; Humans; Influenza Vaccines; Influenza, Human; Occupational Health; Oseltamivir; Pneumonia | 2007 |
Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and children.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cohort Studies; Female; Health Expenditures; Hospitalization; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Middle Aged; Oseltamivir; Otitis Media; Pneumonia; Retrospective Studies | 2008 |
Outcome of influenza infection managed with oseltamivir in lung transplant recipients.
Topics: Adult; Antiviral Agents; Cohort Studies; Female; Humans; Influenza, Human; Lung Transplantation; Male; Middle Aged; Oseltamivir; Pneumonia; Postoperative Complications; Retrospective Studies; Treatment Outcome | 2008 |
Flu-fighting options: decisions, decisions....
Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir | 2000 |
[Pneumonia diagnosis in the practice on the test-bench: how much diagnosis is necessary?].
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Diagnosis, Differential; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pneumonia; Pyrans; Research; Sialic Acids; Time Factors; Zanamivir | 2002 |